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Abstract
Background: Large-scale genetic association studies can test hundreds of thousands of genetic
markers for association with a trait. Since the genetic markers may be correlated, a Bonferroni
correction is typically too stringent a correction for multiple testing. Permutation testing is a
standard statistical technique for determining statistical significance when performing multiple
correlated tests for genetic association. However, permutation testing for large-scale genetic
association studies is computationally demanding and calls for optimized algorithms and software.
PRESTO is a new software package for genetic association studies that performs fast computation
of multiple-testing adjusted P-values via permutation of the trait.
Results: PRESTO is an order of magnitude faster than other existing permutation testing software,
and can analyze a large genome-wide association study (500 K markers, 5 K individuals, 1 K
permutations) in approximately one hour of computing time. PRESTO has several unique features
that are useful in a wide range of studies: it reports empirical null distributions for the top-ranked
statistics (i.e. order statistics), it performs user-specified combinations of allelic and genotypic tests,
it performs stratified analysis when sampled individuals are from multiple populations and each
individual's population of origin is specified, and it determines significance levels for one and two-
stage genotyping designs. PRESTO is designed for case-control studies, but can also be applied to
trio data (parents and affected offspring) if transmitted parental alleles are coded as case alleles and
untransmitted parental alleles are coded as control alleles.
Conclusion: PRESTO is a platform-independent software package that performs fast and flexible
permutation testing for genetic association studies. The PRESTO executable file, Java source code,
example data, and documentation are freely available at http://www.stat.auckland.ac.nz/~browning/
presto/presto.html.
Background
Permutation testing is often described as the gold-stand-
ard for determining statistical significance when perform-
ing multiple correlated tests for genetic association.
Permutation testing can be applied to both case-control
studies and trio studies (parents and affected offspring).
In permutation testing, the case/control status of the indi-
viduals (for case-control studies) or the transmitted/
untransmitted status of the parental chromosomes (for
trio studies) are randomly permuted. The maximum test
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statistic, maximized over all tests for all markers, is calcu-
lated for the original affection/transmission status and for
each permuted affection/transmission status. If k out of P
permutations have a maximum test statistic greater than
the maximum test statistic for the original data, the multi-
ple-testing adjusted P-value for the experiment is (k+1)/
(P+1) [1].
Permutation testing is computationally demanding for
large-scale genetic association studies and requires an
optimized software implementation. The PRESTO soft-
ware package provides fast permutation testing for
genome-wide association studies with thousands or mil-
lions of markers genotyped on thousands of samples. In
addition to using permutation of the trait status to deter-
mine statistical significance of user-specified allelic and
genotypic tests, PRESTO has three additional useful fea-
tures: it can compute empirical distributions of order sta-
tistics so that the significance of sophisticated multi-
marker statistics such as truncated products can be deter-
mined [2,3], it can perform stratified tests when sampled
individuals are from multiple populations and each indi-
vidual's population of origin is specified, and it can com-
pute significance levels for two-stage genotyping designs
using only first-stage genotyping data [4].
Implementation
Features
PRESTO is designed to be flexible and user-friendly. Input
files have a simple format with rows corresponding to
markers and columns corresponding to individuals (two
columns per diploid genotype). This format is well-suited
to large-scale genetic studies where there are typically
many more markers (rows) than individuals (columns).
Genetic marker data can be split up over multiple input
files (e.g. one file per chromosome). There are no restric-
tions on how alleles or missing data are coded, and any
sequence of non-white space characters can be used.
Multi-allelic markers are permitted and are analyzed by
creating a diallelic marker for each allele (grouping the
other alleles) and testing each diallelic marker for associ-
ation with the trait status. If the cases and controls are
sampled from a stratified population and the strata are
specified, PRESTO will automatically perform stratified
allelic and genotypic tests [5,6] and will permute the trait
status within each population stratum.
PRESTO can also compute significance levels of combined
single locus and multi-locus analysis by representing clus-
ters of haplotypes as diallelic markers as described in
Browning and Browning [7]. By default, PRESTO per-
mutes case-control status for individuals; however, it can
also permute case-control status for chromosomes, so that
transmitted/untransmitted data from trio studies (parents
and affected offspring) can be analyzed.
PRESTO performs a Cochran-Mantel-Haenszel (CMH)
test with continuity correction and a Mantel trend test
[5,6]. The CMH test is a generalization to stratified data of
the standard chi-square test of independence, and the
Mantel trend test is a generalization to stratified data of
the allelic trend test. When there is only one population
stratum, these test statistics are equal to the standard test
statistics after multiplying by N/(N-1) where N is the sam-
ple size. The CMH test is used to test for recessive, domi-
nant, or overdominant effects. Although the CMH test can
be used to test for allelic effects, the Mantel trend test is the
preferred allelic test since it is robust to departure from
Hardy-Weinberg equilibrium.
For each permutation of the trait status, PRESTO can store
and report the top-ranked order statistics. The j-th order
statistic is the j-th largest test statistic. For each marker, the
test statistic is the largest allelic or genotypic test statistic
for that marker. The empirical distributions of the top-
ranked order statistics enable one to calculate an empiri-
cal P-value for any order statistic or any function of order
statistics. An example of a function of order statistics is the
j-th rank truncated product statistic, which is defined as
the product of the nominal P-values of the j largest test sta-
tistics [2]. Rank truncated product statistics are useful for
detecting association of multiple top-ranked markers with
a trait, even when no individual marker has a significant
multiple-testing adjusted P-value.
PRESTO can also calculate significance levels for two-stage
genotyping designs from the first-stage genotype data
using the technique described by Dudbridge [4]. In a two-
stage genotype design, the sample is divided into two
stages, a set of markers is genotyped in the first stage sam-
ple, and only the subset of first-stage markers with test sta-
tistics greater than a specified threshold are genotyped in
the second stage sample. PRESTO samples the null distri-
bution of the top-ranked order statistics for a two-stage
genotyping design by using a subset of the first stage sam-
ple as a simulated first stage sample and the remainder of
the first stage sample as a simulated second stage sample
[4].
Optimization techniques
PRESTO employs several techniques to optimize permu-
tation testing on large-scale data sets. The permutations of
the trait status are computed once and are stored. Each
permutation of the trait status is represented as an array of
Boolean (1 bit) variables in which the k-th binary indica-
tor gives the affection status of the k-th chromosome in
the input file. Each genetic marker is read once and is
tested against all stored permutations of the trait status, so
that only one marker is stored in memory at a time.BMC Bioinformatics 2008, 9:309 http://www.biomedcentral.com/1471-2105/9/309
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For each permutation of the trait status and each diallelic
marker, a 2 × 3 contingency table is created where the
rows are the cases and controls and the columns are the
three possible genotypes. PRESTO obtains the 2 × 3 con-
tingency table counts without having to check the per-
muted trait status and genotype for all individuals.
Instead, PRESTO stores the indices of individuals with
missing genotypes, heterozygote genotypes, and minor
(least common) allele homozygote genotypes. The indi-
ces of individuals with major allele homozygote geno-
types do not need to be stored because the case and
control major allele homozygote genotype counts can be
calculated from the case and control sample sizes, the case
and control missing genotype counts, and the case and
control heterozygote and minor allele homozygote geno-
type counts. For example, if there are N genotypes, and
90% of these are major allele homozygotes, then contin-
gency tables for each permutation of the trait status are
constructed by examining the permuted trait status of N/
10 individuals instead of N individuals. This optimization
is expected to be increasingly effective as denser marker
sets are developed since markers with low minor allele fre-
quency are much more numerous than markers with high
minor allele frequency. An analogous optimization is
used to obtain allele contingency table counts.
Output files
PRESTO produces three output files: a log file, a P-value
file, and a null distribution file. The log file summarizes
the analysis and reports the command line parameters,
the running time, and a list of all markers with a multiple-
testing adjusted P-value less than 0.2.
The P-value file gives the chi-square test statistics for each
allelic and genotypic test performed for each marker, and
the permutation P-value for the maximum test statistic for
each marker (maximized over all allelic and genotypic
tests for the marker). If a marker has a maximum test sta-
tistic t0 when tested for association with the unpermuted
trait status, and if for k out of P permutations of the trait
status there exists at least one marker with a maximum test
statistic ≥ t0, then the multiple-testing adjusted P-value for
the marker is (k+1)/(P+1) [1]. The P-value file has a sim-
ple format and can be read into standard statistical soft-
ware packages, such as R [8] for filtering and sorting. An R
script for displaying QQ-plots of P-value distributions is
available from the PRESTO web site.
The null distribution file gives the largest test statistics for
each permutation of the trait status. If there are P permu-
tations and the K largest test statistics are saved, then the
null P-value file is a P × K white-space delimited matrix
whose rows correspond to permutations and whose col-
umns are the empirical distributions of the top-ranked
order statistics. The entry in row i and column j is the j-th
largest test statistic for the i-th permutation. Thus the j-th
column gives the empirical distribution of the j-th largest
test statistic.
Results
Computational time
Table 1 gives PRESTO running times for different scenar-
ios when analyzing 449,446 autosomal markers geno-
typed in 2938 controls and 1749 Crohn's disease patients
from the Wellcome Trust Case Control Consortium study
[9]. The data were analyzed as a single population and as
a stratified population with strata defined by the geo-
graphical origin of the samples within the United King-
dom. For the stratified analysis, the median stratum size
was 584 individuals (range: 296 – 1542 individuals). For
the two-stage genotyping scenarios, the empirical null dis-
tributions of the top-ranked order statistics were calcu-
lated assuming that only markers with a chi-square test
statistic ≥ 10.0 (p = 0.0016) on an allelic, recessive, or
dominant test were selected for genotyping in the second
stage.
Running times for PRESTO 1.0.1 and PLINK 1.0 [10] were
compared for this same data set on the same computer
using a chi-square allelic test, 1000 permutations of the
trait status, and a single population stratum. PRESTO was
approximately 18 times faster than PLINK (50 minutes vs.
15 hours).
PRESTO's running time is linear in the number of sam-
ples, linear in the number of markers and linear in the
number of permutations. Generally, 1000 permutations
are sufficient to determine experiment-wide significance.
PRESTO can also be run in parallel as described in the
documentation.
Memory requirements
Since only one marker is stored in memory at a time and
since the trait status for each individual is stored using 2
Table 1: PRESTO running times for the Wellcome Trust Case 
Control Consortium Crohn's disease study.
# order statistics # strata one-stage study two-stage study
1 1 52.3 m 33.8 m
1 12 84.9 m 55.1 m
1000 1 56.6 m 34.3 m
1000 12 85.6 m 58.5 m
PRESTO computational times for 449,446 autosomal markers 
genotyped in 1749 cases and 2938 controls. Allelic trend test and 
dominant/recessive genotypic tests were performed using 1000 
permutations of the trait status for 8 scenarios defined by the number 
of genotyping stages (1 or 2), the number of order statistic 
distributions calculated (1 or 1000), and the number of population 
strata (1 or 12). Running times were measured on an Intel Core 2 
Duo processor E6600, 2.4 GHz processor with 4 GB of memory 
running Linux.BMC Bioinformatics 2008, 9:309 http://www.biomedcentral.com/1471-2105/9/309
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bits, PRESTO's memory requirements are modest. If there
are P permutations, N individuals, and the distributions
of the top K order statistics are reported, then 2NP/8 bytes
are allocated to store the permutations of the trait status
and 8KP bytes are allocated to store the top-ranked order
statistics (8 bytes per floating point number). In practice,
500 Mb of memory should suffice for values of P  ≤
10,000, K ≤ 2000, and N ≤ 20,000.
Discussion
Permutation testing with 1000 permutations of a large
case-control genome-wide association study with 5000
individuals genotyped for 500,000 markers can be per-
formed using PRESTO in approximately one hour of com-
puting time (Table 1). With PRESTO, the costs of
permutation testing (in terms of time and computing
resources) are extremely low for many common study
designs, and these costs compare very favourably to the
costs associated with data generation (e.g. performing
genotype assays, calling genotypes, and performing data
quality control filtering).
There has been some debate regarding the number of per-
mutations required. When performing N permutations,
the smallest multiple-testing adjusted P-value one can
observe is 1/(N+1) [1]. Thus, 1000 permutations can pro-
vide multiple-testing adjusted P-values as low as 0.001,
which provide strong evidence of association. In the anal-
ysis of Wellcome Trust Case Control Consortium data
described in Table 1, multiple-testing adjusted P-values of
0.05, 0.01, and 0.005 correspond to nominal P-values of
7.5 × 10-8, 1.5 × 10-8, and 6.2 × 10-9 respectively. If addi-
tional permutations are desired, 104 or 105 permutations
are easily performed on a large genome-wide data set like
the WTCCC data set in Table 1, and even larger numbers
of permutations can be easily performed for smaller stud-
ies (computation time is linear in the number of permu-
tations).
Permutation testing is particularly appealing because of its
simplicity. Recently, several more complex alternatives to
permutation testing have been proposed [11-14]. These
methods can be useful, more computationally efficient
alternatives to permutation testing in some situations.
Some methods for computing adjusted P-values exploit
the fact that for many common statistical tests, the corre-
lated tests have an asymptotic multivariate normal distri-
bution under the null hypothesis of no trait-marker
correlation. Seaman and Müller-Myhsok have proposed
estimating the asymptotic distribution and sampling
directly from it [14], and Conneely and Boehnke have
proposed estimating the asymptotic distribution and cal-
culating probabilities under this distribution using
numerical integration [11]. Either approach can be used
to estimate the probability of observing a minimum P-
value smaller than the observed minimum P-value. Both
approaches are particularly well-suited to situations where
covariate data are available or multiple quantitative phe-
notypes are tested. When the asymptotic distribution is
accurately estimated, these methods are shown to give
accurate results (compared to permutation as the gold
standard) for candidate gene studies.
There are some limitations with these approaches that
estimate the asymptotic multivariate normal distribution
of the test statistics. These methods do not estimate signif-
icance levels for two-stage genotyping designs. A more
severe restriction is that these methods are typically lim-
ited to several hundred correlated tests. Seaman and
Müller-Myhsok and Conneely and Boehnke suggest that
the number of samples should be at least 10 times the
number of tests performed in order to accurately estimate
the asymptotic multivariate normal distribution [11,14].
So these methods cannot be directly applied to hundreds
of thousands of single marker tests in a genome-wide
association study.
Other alternatives to permutation testing are based on
importance sampling. Kimmel and Shamir [13] have pro-
posed a method that uses importance sampling to accu-
rately estimate extremely small multiple-testing adjusted
P-values, and Kimmel and colleagues [12] have modified
this method to work with data from a stratified popula-
tion. Decay of linkage disequilibrium with increasing
genomic distance is exploited to further improve the com-
putational efficiency of these methods.
These importance sampling methods lack some of the fea-
tures that are found in PRESTO. The methods do not cal-
culate significance for two-stage genotyping designs, and
they do not calculate adjusted P-values for general order
statistics. In the extension to stratified data, the associa-
tion test statistic used in Kimmel et al [12] will have sub-
optimal power because it ignores the population structure
of the data (the population structure is incorporated in
the importance sampling, but not in the test statistic). The
method of Kimmel and colleagues [12] can be modified
to use a test statistic for stratified data (such as those used
in PRESTO), but this would dramatically increase the
computation time because their method loops through all
possible contingency tables for each sampled permuta-
tion, and the number of contingency tables consistent
with a permutation increases exponentially with the
number of population strata.
Methods for computing multiple-testing adjusted P-val-
ues that are based on asymptotic multivariate normal dis-
tributions or importance sampling, are more complex
than permutation testing, and require the asymptoticPublish with BioMed Central    and   every 
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approximations to be accurate. In addition, when testing
a single binary trait, these alternative methods provide lit-
tle or no decrease in computational time relative to per-
mutation testing with PRESTO, unless one is performing
more than 1000 permutations.
Conclusion
PRESTO is a flexible, platform-independent software
package that determines multiple-testing adjusted statisti-
cal significance for large-scale genetic association studies
by using permutation of the trait status. PRESTO is faster
than existing permutation testing software and can ana-
lyze a large genome-wide association study (500 K mark-
ers, 5 K individuals, 1 K permutations) in approximately
one hour of computing time. PRESTO can be used with
stratified data from multiple populations and with two-
stage genotyping designs. PRESTO can also report empiri-
cal null distributions for the top-ranked statistics (i.e.
order statistics) so that statistical significance can be deter-
mined for any test statistic calculated in terms of order sta-
tistics.
Availability and requirements
￿ Project name: PRESTO
￿  Project home page: http://www.stat.auckland.ac.nz/
~browning/presto/presto.html
￿ Operating system(s): Platform independent
￿ Programming language: Java
￿ Other requirements: standard edition (SE) Java Runt-
ime Environment (JRE) 5.0 (or higher)
￿ License: freely available for academic and commercial
use.
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